FDA approves Celgene drug for multiple myeloma

[riky]

FDA approves Celgene drug for multiple myeloma

(Reuters) - U.S. regulators have approved a new drug from Celgene Corp for patients with multiple myeloma whose disease has worsened after being treated with other cancer drugs. The U.S. Food and Drug Administration said on Friday it approved the drug, Pomalyst, also known as pomalidomide, for the most difficult-to-treat patients. Celgene, in an emailed statement, said the drug was priced at about $10,500 per cycle, and clinical trials have shown that the typical course of treatment is about five cycles. ...

Source: You are not allowed to view links. Register or Login